If 25% tariffs go into effect, it could have a big impact on the cost of medical imaging and radiotherapy systems, with many manufacturing facilities in Mexico. 

Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.

End-of-life decisions are often anything but easy. AI might be able to help. 

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated? 

While there have been no reported injuries, a manufacturing error involving debris contamination could potentially kill a patient.

People are still asking if AI will replace doctors or other healthcare workers. 

Don’t judge DeepSeek on the innovativeness of its programming. Judge it on the degree to which it shakes up the economics of the AI market.

The insurance giant said it will link executive compensation to provider and patient satisfaction, in addition to releasing an annual transparency report on claims reimbursement and denials.